Menu

Image of the Day: Original Fin

Researchers identify the genetics underlying the development of dorsal fins in ancient fish.

Apr 2, 2018
The Scientist Staff, The Scientist Staff

A Japanese rice fish (Oryzias latipes) with normal dorsal and paired pectoral/pelvic fins (top). When the ZRS and sZRS enhancers are knocked out, the fins do not develop normally (bottom).J. LETELIER ET AL.

In a study published last month (March 19) in Nature Genetics, scientists found a single genetic enhancer, named ZRS, critical for normal dorsal fin development in Japanese rice fish (Oryzias latipes). In ancient organisms, dorsal fins are the first limbs seen in the fossil record, indicating they were the first to evolve. When the enhancers were deleted in mice, the rodents also developed abnormal limbs, meaning the pathways that evolved in ancient fins have been conserved across all vertebrates.    

J. Letelier et al., “A conserved Shh cis-regulatory module highlights a common developmental origin of unpaired and paired fins,” Nature Genetics, doi:10.1038/s41588-018-0080-5, 2018.

 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.